Dr.Lavanya G S
Dr.Kavitha S, Dr.Annamalai O
Abstract
Methods :60 patients with primary angle closure suspect (PACS), primary angle closure(PAC) were randomised to receive topical nepafenac drops tds (group 1) or Bromfenac drops bd (group 2) after LPI. 2 weeks post LPI anterior chamber inflammation was assessed using SUN criteria, comfort levels were assessed on Likert scale
Results:. 1 in nepafenac group and none in bromfenac group had residual inflammation. But the difference was not stastistically significant (P= 0.47).Comfort scoring on a scale of 1-10, 1 being not comfortable and 10 being very comfortable, there was no difference between groups, Nepafenac 8, Bromfenac 7, p= 0.081.
Conclusion: Nepafenac and Bromfenac eye drops are equally effective in controlling inflammation in patients with PACS and PAC after LPI. Both can be considered in place of steroid eye drops to overcome the adverse effects of steroids abuse.


Leave a Comment